PharmaTher Holdings Ltd. PHRM
CNSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -32.47% | -8.78% | -8.41% | -1.48% | 0.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.27% | -12.06% | -6.19% | -26.61% | -51.73% |
| Operating Income | 48.27% | 12.06% | 6.19% | 26.61% | 51.73% |
| Income Before Tax | 59.59% | 25.95% | 3.00% | 28.42% | 52.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.59% | 25.95% | 3.00% | 28.42% | 52.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.59% | 25.95% | 3.00% | 28.42% | 52.66% |
| EBIT | 48.27% | 12.06% | 6.19% | 26.61% | 51.73% |
| EBITDA | -- | 62.48% | 41.73% | 42.36% | 51.74% |
| EPS Basic | 60.16% | 26.67% | 4.10% | 29.44% | 53.05% |
| Normalized Basic EPS | 44.87% | 21.43% | 0.00% | 22.55% | 50.00% |
| EPS Diluted | 60.16% | 26.67% | 4.10% | 29.44% | 53.05% |
| Normalized Diluted EPS | 44.87% | 21.43% | 0.00% | 22.55% | 50.00% |
| Average Basic Shares Outstanding | 2.99% | 2.23% | 1.62% | 0.81% | 0.23% |
| Average Diluted Shares Outstanding | 2.99% | 2.23% | 1.62% | 0.81% | 0.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |